Wednesday, 20 March 2019
Latest news
Main » Gilead Sciences, Inc. (GILD) Shares Sold by Glenview State Bank Trust DEPT.

Gilead Sciences, Inc. (GILD) Shares Sold by Glenview State Bank Trust DEPT.

11 March 2018

(NASDAQ GILD) traded up $0.08 during trading hours on Thursday, hitting $80.07. Following the sale, the insider now owns 3,046,766 shares in the company, valued at $224,302,912.92. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since March 8, 2017 and is downtrending. It has underperformed by 51.27% the S&P500.

The stock now shows its YTD (Year to Date) performance of 11.66 percent, whereas its Weekly performance stands at 1.6%. FMR LLC now owns 23,037,303 shares of the biopharmaceutical company's stock valued at $1,630,581,000 after buying an additional 258,005 shares in the last quarter. The company has a market cap of $104.55 Billion. The stock decreased 1.07% or $2.38 during the last trading session, reaching $220.87. About 6.21M shares traded. It also increased its holding in Transocean Ltd (NYSE:RIG) by 1.00M shares in the quarter, for a total of 10.74M shares, and has risen its stake in Mylan N V (NASDAQ:MYL). It has outperformed by 61.31% the S&P500.

Among 2 analysts covering Federal Signal (NYSE:FSS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 70% are positive. FBR Capital maintained QVC Group (NASDAQ:QVCA) rating on Thursday, July 20. Maxim Group has "Buy" rating and $94.0 target. The firm earned "Buy" rating on Thursday, June 15 by Oppenheimer. Capital International Investors now owns 11,217,015 shares of the biopharmaceutical company's stock valued at $908,803,000 after buying an additional 5,205,983 shares during the period. As per Monday, August 28, the company rating was maintained by BMO Capital Markets. The stock has a consensus rating of "Buy" and an average price target of $87.12. The stock has "Buy" rating by Needham on Wednesday, July 29. ValuEngine upgraded shares of Gilead Sciences from a "buy" rating to a "strong-buy" rating in a report on Thursday, February 8th. The company was maintained on Tuesday, February 13 by Scotia Capital.

Kynikos Associates Lp, which manages about $4.02B and $339.98M US Long portfolio, decreased its stake in Vaneck Vectors Etf Tr (Call) by 448,000 shares to 130,900 shares, valued at $3.01M in 2017Q3, according to the filing. South Dakota Investment Council invested in 1.55% or 941,765 shares. Its the same as in 2017Q2. Shares for $452,350 were sold by Lutz Laurent Charles. Palouse Management reported 2.51% stake. The California-based Franklin Res has invested 0% in SLM Corporation (NASDAQ:SLM). Virginia Retirement Et Al stated it has 0.02% of its portfolio in SLM Corporation (NASDAQ:SLM). Riverpoint Mngmt Limited Liability Corp reported 3,150 shares stake. 310 are held by Benjamin F Edwards. Lenox Wealth Management Inc accumulated 134 shares. First Mercantile Tru reported 4,590 shares stake. (NASDAQ:GILD) sales have annually surged 21.90% on average, however its earnings per share growth remained at 36.20%. 49,096 were reported by Mirae Asset Investments. Price T Rowe Associate Md reported 26,370 shares. Bank of America upgraded Gilead Sciences, Inc. It also reduced its holding in Spdr S&P 500 Etf Tr (SPY) by 74,072 shares in the quarter, leaving it with 64,128 shares, and cut its stake in Select Sector Spdr Tr (XLF). Jefferies initiated the shares of GILD in report on Wednesday, September 9 with "Hold" rating. Sunbelt owns 7,150 shares or 0.61% of their US portfolio. The insider WILSON GAYLE E sold 60,000 shares worth $4.68M. Shares for $942,109 were sold by Sivaram Srinivasan. D Scott Neal holds 0.03% or 566 shares.

More news: Amputated Man's Leg Used as a Pillow in India

General Motors Company was covered by a number of analysts recently, 8 rated the stock as Buy, 9 rated Outperform, 12 rated Hold, 0 gave an Underperform and 0 rated sell. The stock price of GILD is moving down from its 20 days moving average with -0.13% and isolated positively from 50 days moving average with 0.95%. Statoil Asa had 32 analyst reports since September 11, 2015 according to SRatingsIntel. The firm has "Neutral" rating by Citigroup given on Wednesday, February 8. The firm has "Buy" rating given on Friday, January 27 by Stifel Nicolaus.

USA stocks fell for the first time in four days Tuesday after comments from new Federal Reserve Chair Jerome Powell sent rates higher. As per Wednesday, August 31, the company rating was maintained by Jefferies.

Gilead Sciences (NASDAQ:GILD) last posted its earnings results on Tuesday, February 6th. The rating was downgraded by Bank of America on Thursday, April 28 to "Neutral". The firm has "Outperform" rating by Credit Suisse given on Wednesday, September 14.

Investors sentiment decreased to 0.8 in Q3 2017. The stock price value Change from Open was at 1.25% with a Gap of -0.68%. It is positive, as 96 investors sold GILD shares while 488 reduced holdings.

More news: Huawei Y9 (2018) With Quad Cameras and Android Oreo Goes Official

Other institutional investors and hedge funds also recently made changes to their positions in the company. Alton Gregg H had sold 30,000 shares worth $2.37 million. Following last close company's stock, is 13.09% above their SMA 50 and 0.51% above the 52-week high. Patten & Patten Inc Tn owns 2,590 shares or 0.02% of their United States portfolio. Penobscot Invest Mgmt Comm has invested 0.18% in Gilead Sciences, Inc. (NASDAQ:GILD). Sei Invests Co invested 0.1% in Gilead Sciences, Inc. Neumann Cap Mgmt Limited Company reported 57,474 shares. Gilead Sciences accounts for 1.6% of Denali Advisors LLC's portfolio, making the stock its 27th largest holding. (NASDAQ:GILD). Beech Hill Advisors holds 0.45% or 10,475 shares. Yorktown Mngmt And Rech holds 3,600 shares. Cmt Asset Management has 6,322 shares for 0.02% of their portfolio. California Employees Retirement System holds 0.39% of its portfolio in Gilead Sciences, Inc.

The analysts offering 12 month price targets for Gilead Sciences, Inc. have a median target of $88, with a high estimate of $105 and a low estimate of $71. Hutchin Hill Cap Limited Partnership invested in 52,800 shares or 0.04% of the stock. Sns Fincl Gp Lc stated it has 0.14% in Gilead Sciences, Inc. Morgan Stanley maintained it with "Equal-Weight" rating and $84 target in Wednesday, February 7 report.

Among 35 analysts covering Lowe's Companies Inc. (NASDAQ:GILD) on Monday, October 2. They expect $0.77 EPS, up 20.31% or $0.13 from last year's $0.64 per share. During the same period in the prior year, the business posted $2.70 earnings per share.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

More news: What Do Analysts Suggest For Exxon Mobil Corporation (XOM)